BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2447481)

  • 1. Biochemical pharmacology and DNA-drug interactions by Cl-958, a new antitumor intercalator derived from a series of substituted 2H-[1]benzothiopyrano[4,3,2-cd]indazoles.
    Fry DW; Besserer JA
    Mol Pharmacol; 1988 Jan; 33(1):84-92. PubMed ID: 2447481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro DNA strand scission and inhibition of nucleic acid synthesis in L1210 leukemia cells by a new class of DNA complexers, the anthra[1,9-cd]pyrazol-6(2H)-ones (anthrapyrazoles).
    Fry DW; Boritzki TJ; Besserer JA; Jackson RC
    Biochem Pharmacol; 1985 Oct; 34(19):3499-508. PubMed ID: 2413861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, biochemical pharmacology, electrochemistry and tumour biology of anti-tumour anthrapyrazoles.
    Showalter HD; Fry DW; Leopold WR; Lown JW; Plambeck JA; Reszka K
    Anticancer Drug Des; 1986 Apr; 1(2):73-85. PubMed ID: 2453196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of protein-associated DNA breaks by 10-[diethylaminopropylamino]-6-methyl-5H-pyrido[3',4':4,5]pyrrolo [2,3-g]isoquinoline in cultured L1210 cells and in isolated nuclei: comparison with other topoisomerase II inhibitors.
    Pierson V; Pierre A; Pommier Y; Gros P
    Cancer Res; 1988 Mar; 48(6):1404-9. PubMed ID: 2830964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition by the DNA repair system of DNA structural alterations induced by reversible drug-DNA interactions.
    Lambert B; Segal-Bendirdjian E; Esnault C; Le Pecq JB; Roques BP; Jones B; Yeung AT
    Anticancer Drug Des; 1990 Feb; 5(1):43-53. PubMed ID: 2180423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anthrapyrazoles, a new class of intercalating agents with high-level, broad spectrum activity against murine tumors.
    Leopold WR; Nelson JM; Plowman J; Jackson RC
    Cancer Res; 1985 Nov; 45(11 Pt 1):5532-9. PubMed ID: 4053027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of the interaction of anthrapyrazole anticancer agents with deoxyribonucleic acids: structural requirements for DNA binding, intercalation, and photosensitization.
    Hartley JA; Reszka K; Zuo ET; Wilson WD; Morgan AR; Lown JW
    Mol Pharmacol; 1988 Mar; 33(3):265-71. PubMed ID: 3352592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pharmacology of the anthracycline drug 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1 H-imidazol-2-yl)hydrazone] dihydrochloride (Cl 216,942).
    Bowden GT; Garcia D; Peng YM; Alberts DS
    Cancer Res; 1982 Jul; 42(7):2660-5. PubMed ID: 7083158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, biological activity and DNA interaction of anilinoacridine and bithiazole peptide derivatives related to the anti-tumor drugs m-AMSA and bleomycin.
    Morier-Teissier E; Bailly C; Bernier JL; Houssin R; Helbecque N; Catteau JP; Colson P; Houssier C; Hénichart JP
    Anticancer Drug Des; 1989 Jun; 4(1):37-52. PubMed ID: 2474298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity and DNA strand breaks by 5-iminodaunorubicin in mouse leukemia L1210 cells: comparison with adriamycin and 4'-(9-acridinylamino)methanesulfon-m-anisidide.
    Zwelling LA; Kerrigan D; Michaels S
    Cancer Res; 1982 Jul; 42(7):2687-91. PubMed ID: 6896293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of the DNA breakage and cytotoxic effects of intercalating agents by treatment with sublethal doses of 1-beta-D-arabinofuranosylcytosine or hydroxyurea in L1210 cells.
    Minford J; Kerrigan D; Nichols M; Shackney S; Zwelling LA
    Cancer Res; 1984 Dec; 44(12 Pt 1):5583-93. PubMed ID: 6208999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the bifunctional antitumor intercalator ditercalinium on DNA in mouse leukemia L1210 cells and DNA topoisomerase II.
    Markovits J; Pommier Y; Mattern MR; Esnault C; Roques BP; Le Pecq JB; Kohn KW
    Cancer Res; 1986 Nov; 46(11):5821-6. PubMed ID: 3019538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity study with bioreductive benzoquinone alkylating agents: effects on DT-diaphorase-mediated DNA crosslink and strand break formation in relation to mechanisms of cytotoxicity.
    Fourie J; Guziec F; Guziec L; Monterrosa C; Fiterman DJ; Begleiter A
    Cancer Chemother Pharmacol; 2004 Mar; 53(3):191-203. PubMed ID: 14614574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acenaphtho[1,2-b]pyrrole derivatives as new family of intercalators: various DNA binding geometry and interesting antitumor capacity.
    Zhang Z; Yang Y; Zhang D; Wang Y; Qian X; Liu F
    Bioorg Med Chem; 2006 Oct; 14(20):6962-70. PubMed ID: 16828559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
    Kirshenbaum MR; Chen SF; Behrens CH; Papp LM; Stafford MM; Sun JH; Behrens DL; Fredericks JR; Polkus ST; Sipple P
    Cancer Res; 1994 Apr; 54(8):2199-206. PubMed ID: 8174127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dimethyl sulfoxide and thiourea upon intercalator-induced DNA single-strand breaks in mouse leukemia (L1210) cells.
    Pommier Y; Zwelling LA; Mattern MR; Erickson LC; Kerrigan D; Schwartz R; Kohn KW
    Cancer Res; 1983 Dec; 43(12 Pt 1):5718-24. PubMed ID: 6416668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of cytotoxicity and protein-associated DNA strand breaks for 2-(arylmethylamino)-1,3-propanediols.
    Dorr RT; Bellamy W; Liddil JD; Baker A; Bair KW
    Anticancer Drug Des; 1998 Oct; 13(7):825-35. PubMed ID: 9807165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual topoisomerase I and II inhibition by intoplicine (RP-60475), a new antitumor agent in early clinical trials.
    Poddevin B; Riou JF; Lavelle F; Pommier Y
    Mol Pharmacol; 1993 Oct; 44(4):767-74. PubMed ID: 8232227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection from adriamycin cytotoxicity in L1210 cells by brefeldin A.
    Vichi PJ; Tritton TR
    Cancer Res; 1993 Nov; 53(21):5237-43. PubMed ID: 8106144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-strand DNA breaks induced by chromophore-modified anthracyclines in P388 leukemia cells.
    Capranico G; Soranzo C; Zunino F
    Cancer Res; 1986 Nov; 46(11):5499-503. PubMed ID: 3463414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.